AbbVie Inc. (ABBV) Net income 2016–2025
AbbVie Inc. (ABBV) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$4.2BFY2025 · since FY2016: $6.0B → $4.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $4.2B | -1.2% |
| FY2024 | $4.3B | -12.0% |
| FY2023 | $4.9B | -58.9% |
| FY2022 | $11.8B | +2.5% |
| FY2021 | $11.5B | +150.0% |
| FY2020 | $4.6B | -41.4% |
| FY2019 | $7.9B | +38.6% |
| FY2018 | $5.7B | +7.1% |
| FY2017 | $5.3B | -10.8% |
| FY2016 | $6.0B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ABBV financial trends
ABBV RevenueABBV Net marginABBV Gross profitABBV Gross marginABBV Operating incomeABBV Operating marginABBV Operating cash flowABBV Free cash flowABBV Capital expendituresABBV Return on equityABBV Stock buybacksABBV Dividends paidABBV Total assetsABBV Total liabilitiesABBV Shareholders’ equityABBV overview →